Inflammatory Response of Monocytes/Macrophages in Patients with Systemic Sclerosis
Frontiers in Bioscience-Landmark · 2024
DOI: 10.31083/j.fbl2907259 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2024. Verfasst von Tatiana V Kirichenko und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular and Molecular Pathology of Cardiovascular System, Petrovsky National Research Center of Surgery, 119435 Moscow, Russia. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Monocytes, Macrophages. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Background
Investigation of the inflammatory response of immune cells is a current focus of research on autoimmune disorders. The aim of this study was to evaluate the inflammatory status of monocytes/macrophages in systemic sclerosis (SSc).
Methods
The study included 35 SSc and 25 healthy participants. The secretion of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), monocyte chemoattractant protein-1 (MCP-1), interleukin-8 (IL-8), interleukin-6 (IL-6) was measured by enzyme-linked immunosorbent assay (ELISA) in primary cultures of monocytes/macrophages after stimulation with lipopolysaccharide (LPS) on day 1 and on day 6 of incubation. Impaired tolerance of the immune response was characterized by increased secretion of the inflammatory mediators in response to restimulation.
Results
Basal secretion of all cytokines was significantly higher in SSc patients compared to healthy individuals. The secretion of TNF-α, IL-1β and IL-6 after the initial LPS stimulation, and secretion of IL-1β, MCP-1, IL-6, IL-8 after LPS restimulation, was significantly higher in the SSc group. Eleven SSc patients (31%) showed impaired immune tolerance in terms of MCP-1 secretion. These patients were significantly younger and had a higher level of anti-topoisomerase I (anti-Scl70) antibodies compared to SSc patients with immune tolerance.
Conclusions
This study revealed pro-inflammatory activation and impaired immune tolerance in monocytes/macrophages from SSc patients. The violation of immune response in terms of MCP-1 secretion may be an important factor in the development of chronic inflammation in SSc. MCP-1 may thus be a potential therapeutic target for novel SSc treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Cellular and Molecular Pathology of Cardiovascular System, Petrovsky National Research Center of Surgery, 119435 Moscow, Russia.
- Laboratory of Medical Genetics, Chazov National Medical Research Center of Cardiology, 121552 Moscow, Russia.
- Department of Systemic Rheumatic Diseases, V.A. Nasonova Research Institute of Rheumatology, 115522 Moscow, Russia.
- Medical Institute, Peoples' Friendship University of Russia named after Patrice Lumumba (RUDN University), 117198 Moscow, Russia.
- Department of Organization and Economy of Pharmacy, Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.
Förderung
- Russian Science Foundation
Zitieren
APA
Kirichenko, T. V., Bogatyreva, A. I., Gerasimova, E. V., Popkova, T. V., Markina, Y. V., Markin, A. M., Gerasimova, D. A., & Orekhov, A. N. (2024). Inflammatory Response of Monocytes/Macrophages in Patients with Systemic Sclerosis. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2907259
Vancouver
Kirichenko TV, Bogatyreva AI, Gerasimova EV, Popkova TV, Markina YV, Markin AM, et al. Inflammatory Response of Monocytes/Macrophages in Patients with Systemic Sclerosis. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2907259
BibTeX
@article{Kirichenko2024,
author = {Kirichenko, Tatiana V and Bogatyreva, Anastasia I and Gerasimova, Elena V and Popkova, Tatiana V and Markina, Yuliya V and Markin, Alexander M and Gerasimova, Daria A and Orekhov, Alexander N},
title = {Inflammatory Response of Monocytes/Macrophages in Patients with Systemic Sclerosis},
journal = {Frontiers in Bioscience-Landmark},
year = {2024},
doi = {10.31083/j.fbl2907259}
}
EUVIMED